Tianjin Pharmaceutical Holdings Co., Ltd. (600488.SH) subsidiary obtains the registration certificate for Metoclopramide Hydrochloride Injection.

China Fortune Financial News APP News, Jinyao Pharmaceutical Co., Ltd (600488.SH) announced that its subsidiary Hubei Jinyao Pharmaceutical Co., Ltd (referred to as "Hubei Jinyao") recently received the "Drug Registration Certificate" for Metoclopramide Hydrochloride Injection approved and issued by the National Medical Products Administration.